Peter Guenter News Today

Although the overall survival miss won't cost Bavencio its FDA approval, it puts the drug further behind rival PD-1 combos from Merck & Co. and BMS.

Merck a leading science and technology company today announced a new collaboration with the United Nations Global Initiative on Ageing GIA to provide a training course on critical skills for family carers.

ROCKLAND, Mass., October 05, 2023--EMD Serono, the Healthcare business of Merck KGaA, Darmstadt, Germany in the US and Canada, today announced a new collaboration with the United Nations-Guided Global Initiative on Ageing (GIA) to provide a training course on critical skills for family caregivers. The course, consisting of 5 modules, provides professional instruction and guidance on essential topics in caregiving such as using medical equipment, creating safe environments and overcoming communic

Marcus Kuhnert has decided to step down as Chief Financial Officer and Member of the Executive Board of Merck as of June 30, 2023. He will continue to serve as a Member of the Executive Board of E ...

Investegate announcements from Galapagos NV, Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meeting

Annual Shareholders Meeting Results On April 25, 2023, Galapagos NV held its Annual Shareholders Meeting . The meeting minutes and other documentation... | April 25, 2023

Mechelen, Belgium; 25 April 2023, 22.01 CET; Galapagos NV (Euronext & NASDAQ: GLPG) today announces the approval of all resolutions proposed at its annual shareholders' meeting (AGM)

Merck today announced it has strengthened its Oncology franchise by regaining exclusive worldwide rights to develop, manufacture, and commercialize anti-programmed death ligand-1 (PD-L1) antibody BAVENCIO® (avelumab) following the termination of their Alliance agreement with Pfizer.

Publication of annual report for financial year 2022Annual Shareholders' Meeting proposed resolutions include re-appointment of Board members and appointment of new statutory auditor Mechelen

Investegate announcements from Galapagos NV, Galapagos publishes 2022 annual report and announces Annual Shareholders’ Meeting